
NovoCure Limited NVCR
$ 14.41
-3.13%
Quarterly report 2025-Q2
added 07-24-2025
NovoCure Limited EV/EBITDA Ratio 2011-2026 | NVCR
Annual EV/EBITDA Ratio NovoCure Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -243 | 417 | 1.1 K | -176 | -64.3 | -4.73 | -2.81 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.1 K | -243 | 146 |
EV/EBITDA Ratio of other stocks in the Health care industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
19.2 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
9.45 | $ 279.23 | -1.65 % | $ 76.5 B | ||
|
Triple-S Management Corporation
GTS
|
79.5 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
16.1 | - | -0.19 % | $ 2.49 B | ||
|
Centene Corporation
CNC
|
26.4 | $ 46.81 | -0.25 % | $ 24.4 B | ||
|
CVS Health Corporation
CVS
|
16.2 | $ 80.31 | -0.36 % | $ 101 B | ||
|
Humana
HUM
|
21.3 | $ 277.28 | -0.1 % | $ 33.4 B | ||
|
Molina Healthcare
MOH
|
20.4 | $ 181.9 | -0.87 % | $ 10.4 B | ||
|
UnitedHealth Group Inc.
UNH
|
21.6 | $ 344.79 | -0.59 % | $ 318 B |